Guidance for industry immediate release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing, and in vivo bioequivalence documentation.
Saved in:
Other Authors: | Center for Drug Evaluation and Research (U.S.) |
---|---|
Format: | Electronic |
Language: | English |
Published: |
[Rockville, Md.] :
Center for Drug Evaluation and Research,
[1995]
|
Physical Description: |
1 electronic resource (26, 1 page) |
Subjects: | |
Online Access: |
https://purl.fdlp.gov/GPO/LPS121078 |
In Prospector
Similar Items
-
Guidance for industry SUPAC-MR : modified release solid oral dosage forms : scale-up and postapproval changes, chemistry, manufacturing and controls, in vitro dissolution testing and in vivo bioequivalence documentation
Published: (1997) -
Guidance for industry nonsterile semisolid dosage forms : scale-up and postapproval changes : chemistry, manufacturing, and controls : in vitro release testing and in vivo bioequivalence documentation
Published: (1997) -
Guidance for industry dissolution testing of immediate release solid oral dosage forms
Published: (1997) -
Guidance for industry SUPAC-IR/MR : immediate release and modified release solid oral dosage forms : manufacturing equipment addendum
Published: (1999) -
Guidance for industry waiver of in vivo bioavailability studies for immediate-release soild oral dosage forms based on a biopharmaceutics classification system
Published: (2000)